Sökresultat - Matthias Pinter

Förfina resultatet
  1. 1
    Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy

    Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy av Matthias Pinter, Rakesh K. Jain

    Publicerad 2017
    Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  2. 2
    Review article: systemic treatment of hepatocellular carcinoma

    Review article: systemic treatment of hepatocellular carcinoma av Matthias Pinter, Markus Peck‐Radosavljevic

    Publicerad 2018
    Hämta fulltext Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  3. 3
    Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups

    Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups av Matthias Pinter, Bernhard Scheiner, Markus Peck‐Radosavljevic

    Publicerad 2020
    Hämta fulltext Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  4. 4
    Renin–Angiotensin System Inhibitors to Mitigate Cancer Treatment–Related Adverse Events

    Renin–Angiotensin System Inhibitors to Mitigate Cancer Treatment–Related Adverse Events av Matthias Pinter, Wilhelmus J. Kwanten, Rakesh K. Jain

    Publicerad 2018
    Hämta fulltext Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  5. 5
    The Current Landscape of Immune Checkpoint Blockade in Hepatocellular Carcinoma

    The Current Landscape of Immune Checkpoint Blockade in Hepatocellular Carcinoma av Matthias Pinter, Rakesh K. Jain, Dan G. Duda

    Publicerad 2020
    Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  6. 6
    Cancer and liver cirrhosis: implications on prognosis and management

    Cancer and liver cirrhosis: implications on prognosis and management av Matthias Pinter, Michael Trauner, Markus Peck‐Radosavljevic, Wolfgang Sieghart

    Publicerad 2016
    Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  7. 7
    NASH and Hepatocellular Carcinoma: Immunology and Immunotherapy

    NASH and Hepatocellular Carcinoma: Immunology and Immunotherapy av Matthias Pinter, David J. Pinato, Pierluigi Ramadori, Mathias Heikenwälder

    Publicerad 2022
    Hämta fulltext Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  8. 8
    The effects of sorafenib on the portal hypertensive syndrome in patients with liver cirrhosis and hepatocellular carcinoma – a pilot study

    The effects of sorafenib on the portal hypertensive syndrome in patients with liver cirrhosis and hepatocellular carcinoma – a pilot study av Matthias Pinter, Wolfgang Sieghart, Thomas Reiberger, Nataliya Rohr‐Udilova, Arnulf Ferlitsch, Markus Peck‐Radosavljevic

    Publicerad 2011
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  9. 9
    Sorafenib in Unresectable Hepatocellular Carcinoma from Mild to Advanced Stage Liver Cirrhosis

    Sorafenib in Unresectable Hepatocellular Carcinoma from Mild to Advanced Stage Liver Cirrhosis av Matthias Pinter, Wolfgang Sieghart, Ivo Graziadei, Wolfgang Vogel, A Maieron, Robert Königsberg, Adalbert Weißmann, Gabriela Kornek, Christina Plank, Markus Peck‐Radosavljevic

    Publicerad 2009
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  10. 10
    Efficacy and Safety of Atezolizumab and Bevacizumab in the Real-World Treatment of Advanced Hepatocellular Carcinoma: Experience from Four Tertiary Centers

    Efficacy and Safety of Atezolizumab and Bevacizumab in the Real-World Treatment of Advanced Hepatocellular Carcinoma: Experience from Four Tertiary Centers av Vera Himmelsbach, Matthias Pinter, Bernhard Scheiner, Marino Venerito, Friedrich Sinner, Carolin Zimpel, Jens U. Marquardt, Jörg Trojan, Oliver Waidmann, Fabian Finkelmeier

    Publicerad 2022
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  11. 11
    Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol

    Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol av Thomas Reiberger, Gregor Ulbrich, Arnulf Ferlitsch, B.A. Payer, Philipp Schwabl, Matthias Pinter, Birgit Heinisch, Michael Trauner, Ludwig Kramer, Markus Peck‐Radosavljevic

    Publicerad 2012
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  12. 12
    Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality

    Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality av Dalila Costa, Benedikt Simbrunner, Mathias Jachs, Lukas Hartl, David Bauer, Rafael Paternostro, Philipp Schwabl, Bernhard Scheiner, Albert Friedrich Stättermayer, Matthias Pinter, Michael Trauner, Mattias Mandorfer, Thomas Reiberger

    Publicerad 2020
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  13. 13
    Prognostic performance of non-invasive tests for portal hypertension is comparable to that of hepatic venous pressure gradient

    Prognostic performance of non-invasive tests for portal hypertension is comparable to that of hepatic venous pressure gradient av Mathias Jachs, Lukas Hartl, Benedikt Simbrunner, Georg Semmler, Lorenz Balcar, Benedikt Hofer, Michael Schwarz, David Bauer, Albert Friedrich Stättermayer, Matthias Pinter, Michael Trauner, Thomas Reiberger, Mattias Mandorfer

    Publicerad 2024
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  14. 14
    A bilateral tumor model identifies transcriptional programs associated with patient response to immune checkpoint blockade

    A bilateral tumor model identifies transcriptional programs associated with patient response to immune checkpoint blockade av Ivy X. Chen, Kathleen Newcomer, Kristen E. Pauken, Vikram R. Juneja, Kamila Naxerova, M. Wu, Matthias Pinter, Debattama R. Sen, Meromit Singer, Arlene H. Sharpe, Rakesh K. Jain

    Publicerad 2020
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  15. 15
    Study protocol: Fecal Microbiota Transplant combined with Atezolizumab/Bevacizumab in Patients with Hepatocellular Carcinoma who failed to achieve or maintain objective response to Atezolizumab/Bevacizumab – the FAB-HCC pilot study

    Study protocol: Fecal Microbiota Transplant combined with Atezolizumab/Bevacizumab in Patients with Hepatocellular Carcinoma who failed to achieve or maintain objective response to... av Katharina Pomej, Adrian Frick, Bernhard Scheiner, Lorenz Balcar, Larissa Pajancic, Anton Klotz, Alexander Kreuter, Katharina Lampichler, Katharina Regnat, Kerstin Zinober, Michael Trauner, Dietmar Tamandl, Christoph Gasché, Matthias Pinter

    Publicerad 2025
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  16. 16
    Association of Platelet Count and Mean Platelet Volume with Overall Survival in Patients with Cirrhosis and Unresectable Hepatocellular Carcinoma

    Association of Platelet Count and Mean Platelet Volume with Overall Survival in Patients with Cirrhosis and Unresectable Hepatocellular Carcinoma av Bernhard Scheiner, Martha M. Kirstein, Sabine Popp, Florian Hucke, Simona Bota, Nataliya Rohr‐Udilova, Thomas Reiberger, Christian Müller, Michael Trauner, Markus Peck‐Radosavljevic, Arndt Vogel, Wolfgang Sieghart, Matthias Pinter

    Publicerad 2018
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  17. 17
    Decreasing von Willebrand Factor Levels Upon Nonselective Beta Blocker Therapy Indicate a Decreased Risk of Further Decompensation, Acute-on-chronic Liver Failure, and Death

    Decreasing von Willebrand Factor Levels Upon Nonselective Beta Blocker Therapy Indicate a Decreased Risk of Further Decompensation, Acute-on-chronic Liver Failure, and Death av Mathias Jachs, Lukas Hartl, Benedikt Simbrunner, David Bauer, Rafael Paternostro, Bernhard Scheiner, Philipp Schwabl, Albert Friedrich Stättermayer, Matthias Pinter, Ernst Eigenbauer, Peter Quehenberger, Michael Trauner, Thomas Reiberger, Mattias Mandorfer

    Publicerad 2021
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  18. 18
    The Sequential Application of Baveno VII Criteria and VITRO Score Improves Diagnosis of Clinically Significant Portal Hypertension

    The Sequential Application of Baveno VII Criteria and VITRO Score Improves Diagnosis of Clinically Significant Portal Hypertension av Mathias Jachs, Lukas Hartl, Benedikt Simbrunner, David Bauer, Rafael Paternostro, Bernhard Scheiner, Lorenz Balcar, Georg Semmler, Albert Friedrich Stättermayer, Matthias Pinter, Peter Quehenberger, Michael Trauner, Thomas Reiberger, Mattias Mandorfer

    Publicerad 2022
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  19. 19
    Use of inhibitors of the renin–angiotensin system is associated with longer survival in patients with hepatocellular carcinoma

    Use of inhibitors of the renin–angiotensin system is associated with longer survival in patients with hepatocellular carcinoma av Matthias Pinter, Arndt Weinmann, Marcus‐Alexander Wörns, Florian Hucke, Simona Bota, Jens U. Marquardt, Dan G. Duda, Rakesh K. Jain, Peter R. Galle, Michael Trauner, Markus Peck‐Radosavljevic, Wolfgang Sieghart

    Publicerad 2017
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  20. 20
    Safety of direct oral anticoagulants in patients with advanced liver disease

    Safety of direct oral anticoagulants in patients with advanced liver disease av Georg Semmler, Katharina Pomej, David Bauer, Lorenz Balcar, Benedikt Simbrunner, Teresa Binter, Lukas Hartl, Jeannette Becker, Matthias Pinter, Peter Quehenberger, Michael Trauner, Mattias Mandorfer, Ton Lisman, Thomas Reiberger, Bernhard Scheiner

    Publicerad 2021
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:

Sökverktyg: